1.
Bioorg Med Chem Lett
; 16(24): 6293-7, 2006 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17005393
RESUMO
Novel tetrahydroisoquinolines have been developed as potent PPAR ligands. Evaluation of these compounds in PPARgamma responsive models of type 2 diabetes is described.